COLLABORATION and LICENSE AGREEMENT BETWEENCollaboration and License Agreement • March 5th, 2020 • Fulcrum Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 5th, 2020 Company Industry JurisdictionThis Collaboration and License Agreement (this “Agreement”) is entered into as of December 20, 2019 (the “Effective Date”), by and between Fulcrum Therapeutics, Inc., a corporation organized under the laws of the State of Delaware (“Fulcrum”), and Acceleron Pharma Inc., a corporation organized under the laws of the State of Delaware (“Acceleron”). Acceleron and Fulcrum each may be referred to herein individually as a “Party” or collectively as the “Parties.”